## BACKGROUND. Recent clinical studies have demonstrated that tumor angiogenesis is a potent prognostic indicator for breast cancer patients. The quantitation of endothelial growth factors is thought to be useful to assess angiogenic phenotype in the tumor. Among the many new endothelial growth fa
Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis
โ Scribed by Aydan Eroglu; Sukru Gulec; Nejat Akar
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 116 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Studies have shown that microvessel density influences breast-cancer prognosis. Since tumor angiogenesis is considered to be substantially affected by the excretion of vascular endothelial growth factor (VEGF) from tumor cells, we examined whether VEGF concentration is different in malignant and in
## Background: Angiogenesis is essential for tumor growth and metastasis. vascular endothelial growth factor (vegf) is the most potent angiogenic factor identified to date. the authors investigated the correlation between the levels of serum vegf (s-vegf) in patients with nasopharyngeal carcinoma (
histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica